On March 29, 2023, the preliminary bidding result of the eighth round of the national drug bulk-buying launched by the National Healthcare Security Administration was released. Zhaoke Pharmaceutical (Hefei) Company Limited, a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), participated in the bidding and its product Nadroparin Calcium Injection won the bid as a generic drug approved under the new Registration Classification of Chemical Drugs. This is another product following Fondaparinux Sodium Injection that was selected in the government’s centralized medical procurement program.
Thai 
English